UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Botulinum toxin A, brain and pain

Progress in neurobiology, 2014-08, Vol.119-120, p.39-59

2014

Volltextzugriff (PDF)

Aminopyridines Restore Ventilation and Reverse Respiratory Acidosis at Late Stages of Botulism in Mice

The Journal of pharmacology and experimental therapeutics, 2024-02, Vol.388 (2), p.637-646

2024

Volltextzugriff (PDF)

Interneuronal Transfer and Distal Action of Tetanus Toxin and Botulinum Neurotoxins A and D in Central Neurons

Cell reports (Cambridge), 2016-08, Vol.16 (7), p.1974-1987

2016

Volltextzugriff (PDF)

Measurement of botulinum types A, B and E neurotoxicity using the phrenic nerve–hemidiaphragm: Improved precision with in-bred mice

Toxicon (Oxford), 2009-04, Vol.53 (5), p.503-511

2009

Volltextzugriff (PDF)

The immunology of botulinum toxin therapy: A brief summary

Toxicology (Amsterdam), 2022-11, Vol.481, p.153341, Article 153341

2022

Volltextzugriff (PDF)

Targeting botulinum neurotoxin persistence by the ubiquitin-proteasome system

Proceedings of the National Academy of Sciences - PNAS, 2010-09, Vol.107 (38), p.16554-16559

2010

Volltextzugriff (PDF)

Potency Evaluations of Recombinant Botulinum Neurotoxin A1 Mutants Designed to Reduce Toxicity

International journal of molecular sciences, 2024-08, Vol.25 (16), p.8955

2024

Volltextzugriff (PDF)

Injection of high dose botulinum-toxin A leads to impaired skeletal muscle function and damage of the fibrilar and non-fibrilar structures

Scientific reports, 2017-11, Vol.7 (1), p.14746-14, Article 14746

2017

Volltextzugriff (PDF)

Catch and Anchor Approach To Combat Both Toxicity and Longevity of Botulinum Toxin A

Journal of medicinal chemistry, 2020-10, Vol.63 (19), p.11100-11120

2020

Volltextzugriff (PDF)

Characterization of Botulinum Neurotoxin A Subtypes 1 Through 5 by Investigation of Activities in Mice, in Neuronal Cell Cultures, and In Vitro

Infection and Immunity, 2013-10, Vol.81 (10), p.3894-3902

2013

Volltextzugriff (PDF)

Botulinum toxin intoxication requires retrograde transport and membrane translocation at the ER in RenVM neurons

eLife, 2024-08, Vol.12

2024

Volltextzugriff (PDF)

Covalent inhibition of botulinum neurotoxin A – Exploration of warhead reactivity and function using a bifunctional approach

Toxicon (Oxford), 2021-01, Vol.190 (Suupl 1), p.S72-S73

2021

Volltextzugriff (PDF)

Intramuscular Botulinum Neurotoxin Serotypes E and A Elicit Distinct Effects on SNAP25 Protein Fragments, Muscular Histology, Spread and Neuronal Transport: An Integrated Histology-Based Study in the Rat

Toxins, 2024-05, Vol.16 (5), p.225

2024

Volltextzugriff (PDF)

The efficacy and safety of intra-articular botulinum toxin type A injection for knee osteoarthritis: A meta‐analysis of randomized controlled trials

Toxicon (Oxford), 2023-03, Vol.224, p.107026-107026, Article 107026

2023

Volltextzugriff (PDF)

Genetically engineered red cells expressing single domain camelid antibodies confer long-term protection against botulinum neurotoxin

Nature communications, 2017-09, Vol.8 (1), p.423-13, Article 423

2017

Volltextzugriff (PDF)

SV2 Is the Protein Receptor for Botulinum Neurotoxin A

Science (American Association for the Advancement of Science), 2006-04, Vol.312 (5773), p.592-596

2006

Volltextzugriff (PDF)

The role of the single interchains disulfide bond in tetanus and botulinum neurotoxins and the development of antitetanus and antibotulism drugs

Cellular microbiology, 2019-11, Vol.21 (11), p.e13037-n/a

2019

Volltextzugriff (PDF)

Discrimination of the Activity of Low-Affinity Wild-Type and High-Affinity Mutant Recombinant BoNT/B by a SIMA Cell-Based Reporter Release Assay

Toxins, 2022-01, Vol.14 (1), p.65

2022

Volltextzugriff (PDF)

Monitoring Botulinum Neurotoxin A Activity with Peptide-Functionalized Quantum Dot Resonance Energy Transfer Sensors

ACS nano, 2011-04, Vol.5 (4), p.2687-2699

2011

Volltextzugriff (PDF)

Deubiquitinating enzyme VCIP135 dictates the duration of botulinum neurotoxin type A intoxication

Proceedings of the National Academy of Sciences - PNAS, 2017-06, Vol.114 (26), p.E5158-E5166

2017

Volltextzugriff (PDF)

Selection of Candidate Monoclonal Antibodies for Therapy of Botulinum Toxin Type A Intoxications

Toxins, 2024-07, Vol.16 (7), p.284

2024

Volltextzugriff (PDF)

The Therapeutic Effect of Botulinum Toxin Type A on Trigeminal Neuralgia: Are There Any Differences between Type 1 versus Type 2 Trigeminal Neuralgia?

Toxins, 2023-11, Vol.15 (11), p.654

2023

Volltextzugriff (PDF)

Effects of Botulinum Toxin Therapy on Health-Related Quality of Life Evaluated by the Oromandibular Dystonia Rating Scale

Toxins, 2022-09, Vol.14 (10), p.656

Yoshida, Kazuya

2022

Volltextzugriff (PDF)

A Validation of the Equivalence of the Cell-Based Potency Assay Method with a Mouse LD 50 Bioassay for the Potency Testing of OnabotulinumtoxinA

Toxins, 2024-06, Vol.16 (6)

2024

Volltextzugriff (PDF)

Holotoxin Activity of Botulinum Neurotoxin Subtype A4 Originating from a Nontoxigenic Clostridium botulinum Expression System

Applied and Environmental Microbiology, 2014-12, Vol.80 (23), p.7415-7422

2014

Volltextzugriff (PDF)

1 – 25 von 375

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(358)
Mit Volltextzugriff
(336)

Publikationsform

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(344)
Life Sciences & Biomedicine
(304)
Animals
(270)
Botulinum Toxins, Type A - Toxicity
(197)
Mice
(175)
Humans
(127)
Botulinum Toxin
(102)
Clostridium Botulinum
(96)
Toxins
(96)
Biological And Medical Sciences
(95)
Toxicity
(93)
Female
(90)
Male
(87)
Toxicology
(87)
Pharmacology & Pharmacy
(83)
Botulinum Toxins - Toxicity
(77)
Rats
(77)
Botulism
(70)
Neurotoxins
(68)
Microbiology
(59)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Botulinum toxin A, brain and pain

Aminopyridines Restore Ventilation and Reverse Respiratory Acidosis at Late Stages of Botulism in Mice

Interneuronal Transfer and Distal Action of Tetanus Toxin and Botulinum Neurotoxins A and D in Central Neurons

Measurement of botulinum types A, B and E neurotoxicity using the phrenic nerve–hemidiaphragm: Improved precision with in-bred mice

The immunology of botulinum toxin therapy: A brief summary

Targeting botulinum neurotoxin persistence by the ubiquitin-proteasome system

Potency Evaluations of Recombinant Botulinum Neurotoxin A1 Mutants Designed to Reduce Toxicity

Injection of high dose botulinum-toxin A leads to impaired skeletal muscle function and damage of the fibrilar and non-fibrilar structures

Catch and Anchor Approach To Combat Both Toxicity and Longevity of Botulinum Toxin A

Characterization of Botulinum Neurotoxin A Subtypes 1 Through 5 by Investigation of Activities in Mice, in Neuronal Cell Cultures, and In Vitro

Botulinum toxin intoxication requires retrograde transport and membrane translocation at the ER in RenVM neurons

Covalent inhibition of botulinum neurotoxin A – Exploration of warhead reactivity and function using a bifunctional approach

Intramuscular Botulinum Neurotoxin Serotypes E and A Elicit Distinct Effects on SNAP25 Protein Fragments, Muscular Histology, Spread and Neuronal Transport: An Integrated Histology-Based Study in the Rat

The efficacy and safety of intra-articular botulinum toxin type A injection for knee osteoarthritis: A meta‐analysis of randomized controlled trials

Genetically engineered red cells expressing single domain camelid antibodies confer long-term protection against botulinum neurotoxin

SV2 Is the Protein Receptor for Botulinum Neurotoxin A

The role of the single interchains disulfide bond in tetanus and botulinum neurotoxins and the development of antitetanus and antibotulism drugs

Discrimination of the Activity of Low-Affinity Wild-Type and High-Affinity Mutant Recombinant BoNT/B by a SIMA Cell-Based Reporter Release Assay

Monitoring Botulinum Neurotoxin A Activity with Peptide-Functionalized Quantum Dot Resonance Energy Transfer Sensors

Deubiquitinating enzyme VCIP135 dictates the duration of botulinum neurotoxin type A intoxication

Selection of Candidate Monoclonal Antibodies for Therapy of Botulinum Toxin Type A Intoxications

The Therapeutic Effect of Botulinum Toxin Type A on Trigeminal Neuralgia: Are There Any Differences between Type 1 versus Type 2 Trigeminal Neuralgia?

Effects of Botulinum Toxin Therapy on Health-Related Quality of Life Evaluated by the Oromandibular Dystonia Rating Scale

A Validation of the Equivalence of the Cell-Based Potency Assay Method with a Mouse LD 50 Bioassay for the Potency Testing of OnabotulinumtoxinA

Holotoxin Activity of Botulinum Neurotoxin Subtype A4 Originating from a Nontoxigenic Clostridium botulinum Expression System

Suchergebnisse filtern